266 related articles for article (PubMed ID: 18472983)
1. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.
D'Amato G; Salzillo A; Piccolo A; D'Amato M; Liccardi G
Ther Clin Risk Manag; 2007 Aug; 3(4):613-9. PubMed ID: 18472983
[TBL] [Abstract][Full Text] [Related]
2. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
3. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
D'Amato G; Bucchioni E; Oldani V; Canonica W
Treat Respir Med; 2006; 5(6):393-8. PubMed ID: 17154668
[TBL] [Abstract][Full Text] [Related]
4. Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review.
D'Amato G; Stanziola A; Sanduzzi A; Liccardi G; Salzillo A; Vitale C; Molino A; Vatrella A; D'Amato M
Multidiscip Respir Med; 2014; 9(1):23. PubMed ID: 24735949
[TBL] [Abstract][Full Text] [Related]
5. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
D'Amato G; Perticone M; Bucchioni E; Salzillo A; D'Amato M; Liccardi G
Eur Ann Allergy Clin Immunol; 2010 Aug; 42(4):135-40. PubMed ID: 21114196
[TBL] [Abstract][Full Text] [Related]
6. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
7. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
D'Amato G
Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on omalizumab in allergic asthma.
Bang LM; Plosker GL
BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
[TBL] [Abstract][Full Text] [Related]
10. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab: a review of its use in the management of allergic asthma.
Bang LM; Plosker GL
Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
[TBL] [Abstract][Full Text] [Related]
12. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
13. Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.
Pelaia G; Vatrella A; Busceti MT; Gallelli L; Terracciano R; Maselli R
Curr Drug Targets; 2015; 16(2):171-8. PubMed ID: 25523898
[TBL] [Abstract][Full Text] [Related]
14. Update on optimal use of omalizumab in management of asthma.
Pelaia G; Gallelli L; Renda T; Romeo P; Busceti MT; Grembiale RD; Maselli R; Marsico SA; Vatrella A
J Asthma Allergy; 2011; 4():49-59. PubMed ID: 21792319
[TBL] [Abstract][Full Text] [Related]
15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
16. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
D'Amato G; Oldani V; Donner CF
Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
[TBL] [Abstract][Full Text] [Related]
17. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
19. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
D'Amato G
Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
